Associated Papers
Spatially interacting phosphorylation sites and mutations in cancer.
Huang KL et al.
Nature Communications, 2021
33875650 (PubMed )
Supplement: 41467_2021_22481_MOESM4_ESM.xlsx › TableS1.HybridClusters
Multiple-level validation identifies PARK2 in the development of lung cancer and chronic obstructive pulmonary disease.
Lee S et al.
Oncotarget, 2016
27329585 (PubMed )
Supplement: oncotarget-07-44211-s002.pdf
A recurrent mutation in PARK2 is associated with familial lung cancer.
Xiong D et al.
American Journal of Human Genetics, 2015
Select a paper to view details